Key facts
- Notable investors include Shanghai XingZhi Venture Capital Investment.
- Status: Privately Held (backing).
- ·The complete investor list — 1 names
- ·Watchlist + deal alerts for Aimonuo Bio
- ·The full record, as it builds
Funding rounds
No funding rounds for Aimonuo Bio are on record yet — either the company hasn't raised institutional capital, or the raise hasn't surfaced in our sources.
About Aimonuo Bio
Developer of medical devices designed to enhance diagnostic and therapeutic capabilities in healthcare settings. The company offers innovative technology and a rigorous quality management system, enabling healthcare institutions and patients to access reliable, high-performance medical equipment.
- Sector
- Healthcare
- HQ
- Changzhou, China
- Founded
- 2025
- Ownership
- Privately Held (backing)
Aimonuo Bio doesn't have a composite mark yet — a PA Mark is published once enough pricing inputs exist (trade prints, fund marks, round prices). The rest of the record below builds toward it.
Recorded secondary trades
No secondary trades in Aimonuo Bio shares have been recorded yet. When a print lands — third-party, direct report, or platform — it appears here with structure, source, and price.
Institutional fund marks
No SEC-registered fund has reported a fair-value mark on Aimonuo Bio in its N-PORT filings yet. We sweep new filings monthly.